Study of achondroplasia health changes over time
Part of Bones, joints & muscles, Genetic & congenital clinical trials.
This study follows people with achondroplasia to better understand what medical issues happen over time. It may help doctors plan care and recognize patterns earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of achondroplasia confirmed by a doctor (through exam and/or x-ray review)
- You have been seen at specific study hospitals for a genetics (genetic counseling) visit
- You may still be getting care there, or you may no longer be treated there if past records are available
- You do not have a different type of skeletal dysplasia (bone-growth condition) instead of achondroplasia
- There are no other serious medical conditions that the study team says would prevent you from participating
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a virtual (online) approach to better understand achondroplasia across all ages. By collecting medical records from people in the US, researchers hope to learn more about the condition and improve care.
This trial tests a new medicine for children with achondroplasia (a common form of dwarfism). It aims to see if the drug can improve growth. The study is for children aged 2.5 to under 11 years old who have not started puberty and can walk without help.
This study tracks how people with achondroplasia or hypochondroplasia move their arms and legs over time. It uses a small wearable device to measure movement and may help doctors understand daily mobility better.
This trial tests a new medicine (ABSK061) for children with achondroplasia, a common form of dwarfism. It aims to see if the drug is safe and can help with growth. Children age 3 to under 12 may qualify.
This trial tests a new medicine (KK8398) for children with achondroplasia (a common cause of dwarfism). It aims to see if the medicine can help improve bone growth and safety. It may be a good option for children who haven't yet reached their final height and haven't been treated with other growth therapies.
This is a research registry that enrolls people with achondroplasia or hypochondroplasia. It helps researchers collect information about the condition to improve understanding and future studies.
Hear when a new Achondroplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.